Literature DB >> 23725272

Resistant hypercalcaemia in metastatic parathyroid carcinoma.

Samantha E Bowyer1, Alison M White, David T Ransom, John A Davidson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725272     DOI: 10.5694/mja12.11243

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  5 in total

Review 1.  Endocrine neoplasms in familial syndromes of hyperparathyroidism.

Authors:  Yulong Li; William F Simonds
Journal:  Endocr Relat Cancer       Date:  2016-05-20       Impact factor: 5.678

2.  Pitfalls of using denosumab preoperatively to treat refractory severe hypercalcaemia.

Authors:  Yulong Li; Chris Y Fan; Andrea Manni; William F Simonds
Journal:  BMJ Case Rep       Date:  2020-04-28

3.  Parathyroid carcinoma in a 13-year-old girl with a long-term survival.

Authors:  Yoko Omi; Tomoko Yamamoto; Yoji Nagashima; Koichiro Abe; Kumiko Karasawa; Yukichi Tanaka; Takahiro Okamoto
Journal:  Surg Case Rep       Date:  2020-06-22

Review 4.  Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report.

Authors:  Abdallah Roukain; Heba Alwan; Massimo Bongiovanni; Gerasimos P Sykiotis; Peter A Kopp
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-31       Impact factor: 5.555

5.  Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy.

Authors:  Reiner Jumpertz von Schwartzenberg; Ulf Elbelt; Manfred Ventz; Knut Mai; Tina Kienitz; Lukas Maurer; Thomas Rose; Jens C Rückert; Christian J Strasburger; Joachim Spranger
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.